Andrew Goldsweig, MD
Interventional Cardiology · Omaha, NENPI 1457594681
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $33,270 of the $48,794 with a category attached, or 68.2%. 13 manufacturers reported payments, led by Philips North America LLC at 38.6% of the total. 2025 is the largest year on record at $23,549, more than ten times the $1,367 reported in 2019.
Across 90 payments — averaging $542.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$19K
- Abbott$18K
- Boston Scientific$5K
- Edwards Lifesciences$2K
- Medtronic$2K
- Inari Medical, Inc.$1K
- plus $2K from 7 others
Across 135 payments — averaging $4901.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- M.a. Med Alliance S.A.$335K
- Boston Scientific$186K
- Surmodics, Inc.$64K
- Medtronic$51K
- Abbott$27K
What the payments were for
- Consulting fees$33,27068%
- Speaking & faculty fees$4,4009%
- Travel & lodging$8,32617%
- Food & beverage$2,7986%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 6 | $18,811 |
| Abbott | 32 | $18,448 |
| Boston Scientific | 19 | $4,892 |
| Edwards Lifesciences | 3 | $1,859 |
| Medtronic(2 entities) | 12 | $1,564 |
| Inari Medical, Inc. | 3 | $1,250 |
| Abiomed | 5 | $982 |
| Occlutech US LLC | 1 | $400 |
| Cordis US CORP. | 4 | $306 |
| Chiesi USA, Inc. | 2 | $212 |
| Biomarin Pharmaceutical Inc. | 1 | $31 |
| Beckman Coulter, Inc. | 1 | $23 |
| Amgen | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IGT Devices Und$10,200
- AMPLATZER AMULET$9,012
- AMPLATZER TALISMAN$7,750
- (9520) IGT Devices Undivided$4,200
- Watchman$3,330
- (9148) ICE 3D$3,000
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$1,720
- COREVALVE EVOLUT R$1,317
- Educ Ultrasound$1,275
- FLOWTRIEVER CATHETER, S$1,250
- CT THROMBECTOMY SYSTEM KIT$1,250
- Impella$948
- GENERAL - THERAPIES$744
- AMPLATZER$680
- AMPLATZER PICCOLO$405
- MYNX CONTROL VENOUS$156
- KENGREAL 50MG/10ML L$140
- SELUTION SLRPTA$120
How this compares
$48,794 in reported general payments places this provider in the 85th percentile of 50 interventional cardiology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 76 | $116,649 |
| FarxigaDapagliflozin Propanediol | 54 | $66,856 |
| XareltoRivaroxaban | 14 | $13,276 |
| JardianceEmpagliflozin | 13 | $12,363 |
| ClopidogrelClopidogrel Bisulfate | 159 | $2,337 |
| Metoprolol Succinate | 110 | $1,674 |
| Atorvastatin Calcium | 40 | $610 |
| Losartan Potassium | 55 | $581 |
| Spironolactone | 46 | $325 |
| Carvedilol | 31 | $291 |
| Amlodipine Besylate | 27 | $257 |
| Rosuvastatin Calcium | 12 | $236 |
| Doxazosin Mesylate | 12 | $116 |
| Lisinopril | 14 | $109 |
| Furosemide | 25 | $100 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Omaha
- Himanshu AgarwalOmaha$541K
- Poonam VelagapudiOmaha$142K
- Jai ParekhOmaha$44K
- Scott CarolloOmaha$19K
- Shahbaz MalikOmaha$17K
- Toufik HaddadOmaha$14K
- Charles OlsonOmaha$12K
- Haysam AkkadOmaha$11K
- Ajaypaul SukhiOmaha$9K
- Filip OleszakOmaha$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.